Floatz logo

Duloxetine

Irritable Bowel Syndrome

New York State Psychiatric InstituteSmall moleculePhase 4 / ApprovedDormant
BBB
72/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
57/ 100
Competitive Position
95/ 100

Competitive context

9 Active assets in the Irritable Bowel Syndrome cohort.

Asset / SponsorPhaseRating
PROPOFOL
Mount Carmel Health System
Phase 4BB
FENTANYL
Mount Carmel Health System
Phase 4BB
Midazolam
Mount Carmel Health System
Phase 4BB
DESIPRAMINE
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Phase 3BB
Gralise
Shirley Ryan AbilityLab
Phase 4B

View all 21 →

Same molecule, other indications

Duloxetine is also rated in:

diabetic neuropathyActive
A
Indicative · Phase 4
81 / 100
View asset →
fibromyalgiaActive
BBB
Indicative · Phase 4
74 / 100
View asset →
osteoarthritisActive
BBB
Indicative · Phase 4
72 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →